Article Details

Roche touts long-term data of Perjeta combination therapy for breast cancer - Seeking Alpha

Retrieved on: 2022-07-14 19:14:47

Tags for this article:

Click the tags to see associated articles and topics

Roche touts long-term data of Perjeta combination therapy for breast cancer - Seeking Alpha. View article details on HISWAI: https://seekingalpha.com/news/3856956-roche-touts-long-term-data-of-perjeta-combination-therapy-for-breast-cancer%3Fsource%3Dcontent_type%253Areact%257Cfirst_level_url%253Amarket-news%257Csection_asset%253Amain

Excerpt

A combination of Roche's (RHHBY) Perjeta (pertuzumab) and Herceptin (trastuzumab) along chemotherapy bested Herceptin and chemotherapy alone over ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up